Tampa, FL, April 15, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- REMSleep Holdings, Inc. (OTC PINK: RMSL) is experiencing further delays with its Deltawave flagship product as we work through these unprecedented conditions. However, the company is making great strides in designing new product during these conditions. The company has already designed new product that will make a great impact to the sleep apnea and respiratory market. The company has submitted the new designs for molding, so time certainly has not been wasted for the company during this global crisis. The company is expecting patent notification for its Deltawave product soon. Remsleep emphasizes that it is a real company producing real life changing products that are in great demand. The company appreciates its shareholders as always, and its shareholders’ commitment to the company. Remsleep management clearly sees a bright future for the company and we invite shareholders to follow our view.
Additional News and Corporate Updates:
RMSL would like to warn its shareholders and potential investors that material corporate information regarding sales, areas of business and other corporate updates will only be made through press releases, official twitter account, or filings with the SEC. RMSL does not utilize chat rooms, or other online sources to disclose any of its material information. The public should rely only on official press releases, official tweets, and corporate filings for accurate and up to date information regarding RMSL.
REMSleep Holdings, Inc. was founded to design and manufacture devices and products for the treatment of sleep apnea and other respiratory conditions. With over 50 years of collective experience in CPAP therapy, the REMSleep team has extensive knowledge and understanding of CPAP and the challenges of patient compliance. REMSleep Holdings, Inc. has a new patent pending, innovative sleep apnea product that will meet multiple market needs and then be able to reach and address a large percentage of the patient population who continue to struggle with CPAP compliance.
Forward-looking statements.
Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words "may", "will", "should", "continue", "expect", "anticipate", "estimate", "believe", "intend", "plan" or "project" or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company's ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company to obtain sufficient financing to execute the Company's business plan; competition; regulation and anticipated and unanticipated costs and delays, and other risks disclosed in the Company's public disclosure record on file with the relevant securities regulatory authorities. No information in this press release should be construed as any indication whatsoever of the Company's future revenues, results of operations or stock price. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.
Tom Wood
912-590-2001
Twood@remsleep.com